Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of alendronate in treatment of thalassemia-associated osteoporosis: a randomized controlled trial
TCTR20180219004Phase 3Completed
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alendronate in osteoporosis, sponsored by Faculty of Medicine, Chiang Mai University. Started Feb 2018; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on TCTR20180219004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180219004.